Ticker: ACN

Accenture

Software Technology Information Technology Services

Price 249.37

Reco Hold Potential 71 Risk 38 Updated 2026-10-26

Official website

Forecast impact

positive

Target +11.5% target fill 89.7%

Reaction D5 +5.56% · D10 pending fresh confirmed · market trust

Impact Potential +6 · Risk -3 valid until 2026-11-14

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

Accenture is a global professional services company specializing in consulting, technology services, and outsourcing. Its core offerings include digital transformation, technology implementation, and management consulting across various industries. Major business segments encompass strategy and consulting, digital services, technology, and operations. The company generates revenue primarily from client contracts in these segments, focusing on delivering innovative solutions to enhance business performance.

Investment Profile

Accenture's stock presents a balanced investment profile, appealing to investors seeking a mix of growth and income through dividends. The company offers a moderate dividend yield, while its focus on technology and consulting positions it for potential growth. However, recent revenue decline may indicate caution for growth-oriented investors. The stock is suitable for those with a medium to long-term investment horizon, providing reasonable liquidity for various investor experiences.

Category: Software Sector: Technology Industry: Information Technology Services Investment style: Growth Horizon: Medium-term Company type: Blue Chip Company type: Market Leader

Fundamental metrics (experimental) Updated: 2026-10-26

EPS (TTM) — earnings per share for the last 12 months, $: 13.66
Revenue QoQ — quarter-over-quarter revenue growth: -0.2%
EPS surprise: 3.5%
20d volatility: 4.4%
Dividend yield: 2.6%
last ex-date: 2026-10-13

AI recommendation changes

Date	Before	After	Reason
2026-10-24	Buy	Hold	Strong growth but recent volatility raises concerns.
2026-10-01	Hold	Buy	Strong momentum and solid fundamentals support growth potential.
2026-09-29	Buy	Hold	Weak momentum and high risk offset potential upside.
2026-09-22	Hold	Buy	Strong fundamentals, but mixed momentum signals present uncertainty.
2026-09-20	Buy	Hold	Weak momentum and high risk; cautious approach advised.
2026-09-14	Hold	Buy	Strong fundamentals, but mixed momentum signals present uncertainty.
2026-09-05	Buy	Hold	Mixed performance; cautious outlook amid market volatility.
2026-08-27	Hold	Buy	Mixed performance; cautious outlook amid market volatility.
2026-08-19	Buy	Hold	Mixed performance; cautious outlook amid market volatility.
2026-08-02	Hold	Buy	Strong recent performance, but mixed long-term momentum.
2026-07-29	Sell	Hold	Strong recent performance and solid fundamentals support growth.
2026-07-27	Hold	Sell	Mixed performance; high risk and negative momentum persist.
2026-07-20	Sell	Hold	Mixed performance; cautious outlook amid high risk.
2026-06-09	Hold	Sell	Weak fundamentals and negative momentum indicate high risk.
2026-06-01	Sell	Hold	Weak fundamentals and negative momentum raise concerns.
2026-05-24	Hold	Sell	Weak fundamentals and negative momentum raise concerns.
2026-05-16	Sell	Hold	Weak fundamentals and negative momentum raise concerns.
2026-05-08	—	Sell	Weak fundamentals and negative momentum raise concerns.
2026-05-03	Hold	Sell	Компания испытывает давление на выручку и показывает отрицательную динамику за последние месяцы, что увеличивает риски. Однако дивидендная доходность остается привлекательной, что может поддерживать интерес инвесторов.
2026-04-25	Sell	Hold	Компания Accenture испытывает значительное снижение цен на акции в последние месяцы, что указывает на высокие риски. Однако дивидендная доходность остается привлекательной, что может поддерживать интерес инвесторов.
2026-04-15	Hold	Sell	Компания Accenture демонстрирует снижение выручки и значительное падение цены акций за последние месяцы, что указывает на высокие риски. Однако дивидендная доходность остается привлекательной, что может поддерживать инте
2026-04-02	Sell	Hold	Компания демонстрирует стабильные дивиденды и имеет положительный сюрприз по прибыли, однако наблюдается значительное снижение цены акций за последние месяцы, что указывает на высокие риски.
2026-03-25	Hold	Sell	Компания Accenture демонстрирует негативные тренды в краткосрочной перспективе, однако стабильная дивидендная доходность и сильные финансовые показатели могут поддерживать интерес инвесторов.
2026-02-27	Sell	Hold	Несмотря на недавний рост акций, компания испытывает давление на фоне снижения цен за последние 20 и 60 дней. Умеренный рост выручки и дивидендная доходность поддерживают стабильность, но высокие риски требуют осторожнос
2026-02-20	Hold	Sell	Компания Accenture демонстрирует снижение цен на акции в краткосрочной перспективе, однако имеет стабильный рост выручки и дивидендную доходность. Рекомендуется удерживать акции до улучшения рыночной ситуации.
2026-02-12	Sell	Hold	Компания Accenture демонстрирует стабильный рост выручки, но недавние колебания цен и высокая волатильность могут указывать на риски. Рекомендуется удерживать акции до более ясных сигналов о восстановлении.
2026-02-04	Hold	Sell	Существенное снижение цены акций за короткий период и отсутствие данных о прибыли и дивидендах указывают на высокие риски. Текущая ситуация требует осторожности и может свидетельствовать о негативных перспективах компани
2026-01-25	Buy	Hold	Компания показывает положительную динамику на более длительных сроках, однако недавние колебания цен указывают на возможные краткосрочные риски. Рекомендуется удерживать акции до дальнейших сигналов о стабильности.
2026-01-22	Hold	Buy	Компания показывает положительную динамику на рынке с ростом цен за последние 60 дней. Учитывая стабильный спрос на IT-услуги, Accenture имеет хорошие перспективы для дальнейшего роста.

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-10-21	Robert W. Baird	Update	— → 252	239.12
2026-10-15	Stifel Nicolaus	Update	— → 242	226.95
2026-10-15	UBS	Target Raised	275 → 278	227.28
2026-10-15	Susquehanna	Target Raised	210 → 230	214.96
2026-10-06	Mizuho Securities	Target Raised	226 → 241	195.05
2026-10-02	Truist Financial	Target Raised	150 → 220	202.59
2026-10-02	RBC Capital	Target Raised	— → 240	204
2026-10-02	Argus Research	Target Raised	220 → 260	204.03
2026-10-02	BMO Capital	Target Raised	200 → 235	212.3
2026-10-02	Morgan Stanley	Target Raised	175 → 195	212.3
2026-10-02	Wells Fargo	Target Raised	— → 210	212.3
2026-10-02	Jefferies	Target Raised	— → 220	212.3
2026-10-01	Goldman Sachs	Target Raised	230 → 260	212.3
2026-10-01	Susquehanna	Target Raised	153 → 210	214.69
2026-10-01	Robert W. Baird	Target Raised	190 → 245	214.75
2026-10-01	Evercore ISI	Target Raised	180 → 250	216.1
2026-09-28	Susquehanna	Target Raised	140 → 153	173.3
2026-09-23	BMO Capital	Target Raised	— → 200	183.72
2026-09-18	Deutsche Bank	Target Raised	136 → 175	183.53
2026-09-15	RBC Capital	Update	— → 195	195
2026-09-14	Morgan Stanley	Target Raised	130 → 175	189.15
2026-08-25	Wolfe Research	Target Raised	165 → 215	186.53
2026-07-20	Wells Fargo	Target Lowered	200 → 194	143.57
2026-07-10	Deutsche Bank	Target Lowered	140 → 136	139.06
2026-07-08	UBS	Update	— → 275	139.72
2026-06-23	Mizuho Securities	Target Lowered	280 → 226	124.83
2026-06-22	Susquehanna	Target Lowered	186 → 140	125.605
2026-06-22	Morgan Stanley	Target Lowered	177 → 130	127.98
2026-06-22	Truist Financial	Target Lowered	210 → 150	127.98
2026-06-22	RBC Capital	Target Lowered	253 → 175	127.98
2026-06-22	Guggenheim	Target Lowered	225 → 185	127.98
2026-06-22	Wells Fargo	Target Lowered	248 → 200	127.98
2026-06-19	BMO Capital	Target Lowered	230 → 150	127.98
2026-06-18	Robert W. Baird	Target Lowered	265 → 190	127.67
2026-06-18	Evercore ISI	Target Lowered	250 → 180	127.05
2026-06-17	Berenberg Bank	Target Lowered	273 → 220	165.52
2026-06-16	Wolfe Research	Target Lowered	— → 200	165.36
2026-06-15	Morgan Stanley	Update	— → 177	170.28
2026-06-08	Oppenheimer	Target Lowered	— → 201	178.25
2026-06-03	Stifel Nicolaus	Target Lowered	315 → 270	186.22
2026-06-03	Goldman Sachs	Update	— → 270	186.22
2026-06-01	Truist Financial	Update	— → 210	187.07
2026-03-05	Piper Sandler	Target Lowered	— → 282	210
2026-01-22	Berenberg Bank	Update	— → 313	280.72
2026-01-14	Wells Fargo	Target Raised	251 → 275	276.8
2026-01-06	Truist Financial	Update	— → 317	263.98
2025-12-19	Susquehanna	Target Raised	270 → 277	276.06
2025-12-19	UBS	Target Raised	315 → 320	272.66
2025-12-18	Evercore ISI	Target Raised	280 → 300	269.96
2025-12-18	RBC Capital	Target Raised	— → 300	269.96
2025-12-18	BMO Capital	Target Raised	270 → 300	270.13
2025-12-18	RBC Capital	Target Raised	— → 295	269.96

News Page 1 of 2

Anthropic to Invest $100 Million in Claude Frontier Academy to Train AI Engineers

10/02/2026, 02:36 PM economy announcement ai Accenture Morgan Stanley

Anthropic's $100 million investment in the Claude Frontier Academy aims to train 10,000 AI engineers by 2027, addressing the growing demand for AI expertise across industries. This initiative is crucial as it positions Anthropic to enhance its partnerships and potentially strengthen its market presence ahead of its anticipated IPO.

Stocks Surge Midday: Accenture Soars 18%, Synopsys Rises Over 8%, United Therapeutics Jumps 6% Following Court Ruling

10/01/2026, 10:37 AM business review Acuity Brands Liquidia United Therapeutics BJ's Restaurants Amazon Accenture Constellation Energy McKesson Corporation Synopsys CVS Health

Several companies experienced significant stock movements due to earnings reports and legal rulings, highlighting the impact of financial performance and regulatory decisions on market valuations.

Accenture (ACN) Shares Surge Over 20% Following Strong Earnings Report

10/01/2026, 08:38 AM stock_growth consulting finance Accenture

Accenture's shares jumped over 22% following a strong fiscal fourth-quarter earnings report that surpassed analyst expectations, marking a significant recovery for the company amid ongoing concerns about AI disruption.

Stocks to Watch: Alphabet, Accenture, Rocket Lab, Micron, and More Show Significant Premarket Movements

10/01/2026, 05:38 AM business review Micron Alphabet Accenture McCormick Dollar Tree Nu Holdings Rocket Lab

Several companies are experiencing significant premarket trading movements, with Alphabet and Accenture showing notable gains due to strong performance and new product announcements, which could influence investor sentiment in the tech and services sectors.

Stocks Making Significant Premarket Moves: Paramount, Warner Bros., Accenture, Novo, and More

09/21/2026, 05:37 AM business review Arhaus Warner Bros. Discovery Accenture Novo Nordisk Coinbase

Shares of Paramount and Warner Bros. Discovery surged following reports of a potential settlement regarding their merger lawsuit, while Accenture's stock rose after announcing a partnership with Anthropic. Conversely, Novo's shares fell as investors reacted negatively to its long-term goals in the weight loss market.

Anthropic Partners with Accenture to Implement AI Development Slowdown Proposal by CEO Dario Amodei

09/18/2026, 03:36 PM economy announcement ai Accenture

Anthropic's partnership with Accenture marks a significant move towards enhancing AI safety, as both companies commit over $1 billion to this initiative. This development is crucial for investors as it reflects a shift in the AI sector towards more responsible development practices amid growing regulatory scrutiny.

Analysts Goldman Sachs expect bull market to continue despite rising bond yields, recommend short-duration stocks

09/15/2026, 08:37 AM investing forecast Analysts: analysts, Goldman Sachs finance JPMorgan Chase Goldman Sachs Coca-Cola Accenture Whirlpool Moderna

Wall Street analysts suggest that while rising bond yields pose challenges for stocks, they do not foresee a derailment of the current bull market, emphasizing the importance of strategic adjustments in investment approaches.

Analysts recommend trading Accenture (ACN) with a bullish call spread strategy amid market volatility

07/14/2026, 08:37 AM investing recommendation Analysts: analysts software Accenture

Amid ongoing geopolitical tensions and market volatility, Accenture (ACN) is showing bullish indicators, suggesting a potential trading opportunity for investors. The analysis emphasizes the importance of strict trade management in this uncertain environment.

Analysts recommend buying dividend stocks like Abbott Laboratories (ABT) and Accenture (ACN) for portfolio income in 2026

06/26/2026, 11:37 AM investing recommendation Analysts: analysts healthcare finance Accenture Intercontinental Exchange Medtronic Abbott Laboratories

In a high-priced stock market, investors are increasingly looking for undervalued dividend stocks that provide income while they wait for potential price appreciation. This strategy is particularly relevant given the current market volatility and inflation concerns.

Stocks Making Significant Moves Midday: Micron Technology, IBM, Carnival, and More

06/23/2026, 10:37 AM business review Micron SpaceX AMC Entertainment Holdings Exxon Mobil Avis Budget Group Carnival Corporation IBM Accenture

Midday trading saw significant movements in several tech and consumer companies, with Micron Technology leading a selloff in the sector, while Accenture and IBM showed resilience amid broader market declines.